DOCS

Doximity, Inc.

Doximity, Inc.DOCS

Healthcare · Health Information Services

27.93USD

-2.00%

Oct 05, 2026

DOCS overview ready

Doximity operates a large U.S. Clinician network and sells pharmaceutical manufacturers and health systems targeted digital marketing and engagement programs, while increasing clinician utility through communication, research, ambient documentation, and HIPAA-compliant AI tools.

Narrative is still early

Exposed to the Pharmaceutical Commercialization Modernization narrative through Digital Healthcare-Professional Engagement and AI Commercialization — enabling supplier.

Advancing price action

Longer-term context reads early recovery, with a near-term setup of daily reclaim.

Attractive valuation

Current market expectations look undemanding relative to the cash the business actually produces.

Solid fundamentals

Free cash flow yield is strong.

Primary risk

Dependence on continued adoption by medical professionals.

Market Oct 2Filing Jun 30Price action Oct 4Research Oct 3

Conviction Level

Price

Loading price history…

Price Action

Advancing price action

Longer-term context reads early recovery, with a near-term setup of daily reclaim.

EntryReset + recovery

The stock is still rebuilding below its long-term weekly base, and the recent reset toward the daily SMA200 aligned with support at the weekly EMA21. Daily structure is recovering above the fast averages, improving the current entry location.

Key Financials

Market Cap: $5.0B
Avg Volume (60D): 5.1M
Revenue Growth YoY: +13.1%
Gross Margin: +88.1%
Operating Margin: +29.6%
Free Cash Flow Yield: +6.1%
Distance from 200DMA: +4.3%
Next Earnings: 2026-11-05
P/E: 30.1x

Market metrics as of Oct 2, 2026

Financial results for the period ended Jun 30, 2026

Filed balance-sheet data as of Jun 30, 2026

Fundamentals & Valuation

One of the two valuation perspectives says cheap; peers is the dissenting view.

Doximity, Inc. has a Cheap valuation stance because current market expectations look undemanding relative to the cash the business actually produces. It trades at a 6.1% free-cash-flow yield, which the underlying economics comfortably support.

Company Research

Thesis

Opportunity

Moderate opportunity

Life-sciences companies are shifting physician outreach, medical-information delivery, targeting, measurement, and commercial workflows toward data-driven digital channels and AI-enabled engagement.

Key risk

Dependence on continued adoption by medical professionals.

Narrative & Theme

Pharmaceutical Commercialization Modernization

Part of Digital Healthcare-Professional Engagement and AI Commercialization, with moderate fit.

DOCS does not genuinely fit the approved Digital Obesity Care and Access Navigation placement: its core economic exposure is not patient obesity treatment access or navigation.

Narrative HeatNeutral5.0 / 10

Theme HeatNeutral6.6 / 10

This is the company’s own research reading. The canonical heat measurement for this story has not run.

Business & Markets

Healthcare · Health Information Services

What they do

Doximity operates a digital platform for U.S. Medical professionals that provides personalized clinical and professional content, as well as workflow tools to support healthcare communication and collaboration.

How it earns

The company primarily generates revenue through subscription fees and sponsored content from pharmaceutical manufacturers and health systems.

Products & services

Doximity personalized newsfeed

Ask HIPAA-compliant AI assistant

Clinical discussions and professional networking tools

Customers & end markets

Medical professionals in the United States

Pharmaceutical manufacturers

Health systems

Market position

Doximity is a leader in the digital professional network and communication platform space for U.S. Healthcare providers.

Demand drivers

Low cyclicality

Demand for healthcare communication and information services is relatively stable and less sensitive to economic cycles.